HDAC9 and familial pancreatic carcinoma: In pancreatic cancer, several members of the histone deacetylase (HDAC) family have been reported to be overexpressed [12, 13, 14], which in turn have been associated with enhanced resistance to apoptosis, poor tumour differentiation and worse survival [13, 15].